The SAVE Trial: Securing All intraVenous devices Effectively in hospitals. A randomised controlled trial

SAVE 试验：有效保护医院内所有静脉内设备的安全。

• 批准号: nhmrc : 1041910
• 负责人: A/Pr E Geoffrey Playford
• 金额: $ 65.37万
• 依托单位: Griffith University
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-01-01 至 2017-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/save-trial-securing-controlled-trial/111415
• 关键词: SAVE; Trial; Securing; intraVenous; devices

Going to hospital usually means having an IV drip in your hand or arm vein. Almost half of all IV drips fall out or fail because they are not well secured to the skin. This means patients miss out on treatment and have additional painful needlesticks to insert new devices. Serious infections can also occur. This study will find the best dressings to use on IV drips. Patients will have their drips glued in with medical superglue, or have one of two new dressings, compared with current usual care.

去医院通常意味着要在手或手臂静脉中进行静脉滴注。几乎一半的静脉滴注会掉落或失败，因为它们没有很好地固定在皮肤上。这意味着患者会错过治疗，并且需要额外痛苦的针刺来插入新设备。也可能发生严重感染。这项研究将找到最适合静脉滴注的敷料。与目前的常规护理相比，患者将用医用强力胶粘上点滴，或者使用两种新敷料中的一种。